Xtx Topco LTD Synaptogenix, Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 13,342 shares of SNPX stock, worth $53,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,342

Holding current value

$53,634

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$0.16 - $0.3 $2,134 - $4,002	13,342 New	13,342 $2,000
Q3 2023 Nov 13, 2023	BUY	$0.28 - $1.04 $3,204 - $11,900	11,443 New	11,443 $5,000

Others Institutions Holding SNPX

# of Institutions

Shares Held

955K

Call Options Held

Put Options Held

Jim Simons Renaissance Technologies LLC | New York, Ny

401K
Shares

$1.61 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

154K
Shares

$620,973
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

83.5K
Shares

$335,846
0.0% of portfolio
Two Sigma Securities, LLC New York, NY

83.4K
Shares

$335,304
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

68.5K
Shares

$275,458
0.0% of portfolio

View Full List

About Synaptogenix, Inc.

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $27.5M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

More about SNPX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account